<DOC>
	<DOCNO>NCT00314041</DOCNO>
	<brief_summary>Infant phase : To determine safety production antibody group C meningococcal conjugate vaccine ( MnCC ) , give 2 , 3 , 4 month age routine vaccine . Booster phase : To compare safety production antibody MnCC without MMR compare antibody response produce low dose plain polysaccharide vaccine way investigate immune memory</brief_summary>
	<brief_title>Study Evaluating Tolerance Conjugate Meningococcal C Vaccine Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant 710 week age eligible receive routine immunization</criteria>
	<gender>All</gender>
	<minimum_age>7 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Infant</keyword>
	<keyword>Conjugate vaccine</keyword>
	<keyword>Meningococcal</keyword>
	<keyword>Antibody</keyword>
	<keyword>Immune memory</keyword>
	<keyword>Health</keyword>
	<keyword>Meningococcal Vaccines</keyword>
</DOC>